SCHEMBL30945718

SCHEMBL30945718

CNC(=O)NC(=O)CCN1CCc2[nH]c3ccc(Cl)cc3c2C1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BAZ2B Q9UIF8 2/20 0.60
▸ ACHE P22303 3/20 0.48
▸ GRIN1 Q05586 3/20 0.48
▸ GRIN2A Q12879 3/20 0.48
▸ GRIN2D O15399 2/20 0.48
▸ GRIN3B O60391 2/20 0.48
▸ GRIN2B Q13224 2/20 0.48
▸ GRIN2C Q14957 2/20 0.48
▸ GRIN3A Q8TCU5 2/20 0.48
▸ APAF1 O14727 1/20 0.47
▸ GAA P10253 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ CASP7 P55210 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30704375 0.79 ACHE (0.60) BAZ2BACHEGRIN1GRIN2AGRIN2D
SCHEMBL3028678 0.78 BAZ2B (0.57) BAZ2BACHEGRIN1GRIN2AGRIN2D
SCHEMBL30945688 0.77 KDR (0.57) BAZ2BACHEGRIN1GRIN2AGRIN2D
SCHEMBL3716545 0.76 BAZ2B (0.62) BAZ2BACHEGRIN1GRIN2AGRIN2D
SCHEMBL21723856 0.75 BAZ2B (0.52) BAZ2BGRIN2BGAAMEN1KMT2A
SCHEMBL21723990 0.74 PRMT5 (0.61) GAAMEN1MAPTKMT2APOLB
SCHEMBL3034533 0.74 APAF1 (0.84) BAZ2BAPAF1HDAC1HDAC6
SCHEMBL27246706 0.73 ACHE (0.54) BAZ2BACHEGRIN1GRIN2AGRIN2D
SCHEMBL30095900 0.73 ACHE (0.54) BAZ2BACHEGRIN1GRIN2AGRIN2D
SCHEMBL3028608 0.73 BAZ2B (0.55) BAZ2BACHEGRIN1GRIN2AGRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS CULLGEN (SHANGHAI), INC. (CN) 2024-06-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240197694-A1 MODIFIED PROTEINS AND PROTEIN BINDERS DCAF1, DDB1, CUL4A BAZ2B 98/4885ACHE 4434/4885GRIN1 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback